Although I’m a trained and credentialed epidemiologist, and an ardent supporter of the professional discipline as a foundational science that underlies legitimate public health efforts, several of my past blogs (Bond 2016 and Bond 2017) have remarked on the many limitations of observational epidemiology¹ research for establishing disease causation.  

Several contemporary events scheduled for the European Union are bringing increased focus to the topic of communicating risks about Endocrine Disrupting Chemicals (EDCs). The first took place on May 16 at the annual meeting of the European Chapter of the Society of Environmental Toxicology and Chemistry (SETAC) which was held in Rome.

A few weeks ago, I came across a press release issued by the Health and Environment Alliance (HEAL), a European-based  non-governmen

My wife and I annually host Thanksgiving dinner for extended family and friends.  It’s a big affair and since we live in a fairly remote, albeit stunningly beautiful, part of northern Michigan, and our guests have to travel hundreds of miles to get here, the event stretches over multiple days.  One of my responsibilities is to ensure we have sufficient quantity and diversity of alcoholic and non-alcoholic beverages to appeal to all of our guests who span four generations and have varied tastes.

In 2017 the National Academies of Sciences, Engineering, and Medicine (NAS) published a report that it developed for the U.S. Environmental Protection Agency (EPA) to evaluate the evidence that chemicals are capable of causing health effects at low-doses.